New drug PEEL-224 takes on advanced tumors in first human trial
NCT ID NCT05329103
First seen May 16, 2026 · Last updated May 19, 2026 · Updated 1 time
Summary
This study is testing a new drug, PEEL-224, for the first time in people with advanced solid tumors that have not responded to standard treatments. The main goals are to find the safest dose and to see if the drug can shrink tumors. About 65 participants will take part in this early-phase trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Abramson Cancer Center at Pennsylvania Hospital
COMPLETEDPhiladelphia, Pennsylvania, 19106, United States
-
Carolina BioOncology Institute
COMPLETEDHuntersville, North Carolina, 28078, United States
-
HonorHealth Research Institiute
RECRUITINGScottsdale, Arizona, 85258, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Huntsman Cancer Institute, University of Utah
RECRUITINGSalt Lake City, Utah, 84112, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Mary Crowley Cancer Research
COMPLETEDDallas, Texas, 75230, United States
-
NEXT Virginia
RECRUITINGFairfax, Virginia, 22031, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Rhode Island Hospital
RECRUITINGProvidence, Rhode Island, 02903, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Stanford Cancer Center
ACTIVE_NOT_RECRUITINGPalo Alto, California, 94305, United States
Conditions
Explore the condition pages connected to this study.